{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T14:45:31Z","timestamp":1764341131595,"version":"3.46.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-00273553"],"award-info":[{"award-number":["RS-2023-00273553"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS027623"],"award-info":[{"award-number":["R01HS027623"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K01AG068365"],"award-info":[{"award-number":["K01AG068365"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-04475-3","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:24:56Z","timestamp":1764332696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opioid overdose associated with concomitant use of hydrocodone and selective serotonin reuptake inhibitors"],"prefix":"10.1186","volume":"23","author":[{"given":"Sungho","family":"Bea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krista F.","family":"Huybrechts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seanna M.","family":"Vine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Belitkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsiaryna","family":"Bykov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"3","key":"4475_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain\u2013United States, 2022. MMWR Recomm Rep. 2022;71(3):1\u201395.","journal-title":"MMWR Recomm Rep"},{"issue":"13","key":"4475_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJMra1507771","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, McLellan AT. Opioid abuse in chronic pain: misconceptions and mitigation strategies. N Engl J Med. 2016;374(13):1253\u201363.","journal-title":"N Engl J Med"},{"issue":"11","key":"4475_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","volume":"69","author":"N Wilson","year":"2020","unstructured":"Wilson N, Kariisa M, Seth P, Smith Ht, Davis NL. Drug and opioid-involved overdose deaths\u2013United States, 2017\u20132018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"unstructured":"Centers for Disease Control and Prevention. Overdose prevention. Available from: https:\/\/www.cdc.gov\/drugoverdose\/prevention.","key":"4475_CR4"},{"issue":"7","key":"4475_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/archinternmed.2011.117","volume":"171","author":"T Gomes","year":"2011","unstructured":"Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171(7):686\u201391.","journal-title":"Arch Intern Med"},{"issue":"1","key":"4475_CR6","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41598-024-52032-4","volume":"14","author":"AJ Schoenfeld","year":"2024","unstructured":"Schoenfeld AJ, Munigala S, Gong J, Schoenfeld RJ, Banaag A, Coles C, et al. Reductions in sustained prescription opioid use within the United States between 2017 and 2021. Sci Rep. 2024;14(1):1432.","journal-title":"Sci Rep"},{"issue":"1","key":"4475_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","volume":"19","author":"EF McCance-Katz","year":"2010","unstructured":"McCance-Katz EF, Sullivan LE, Nallani S. Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. Am J Addict. 2010;19(1):4\u201316.","journal-title":"Am J Addict"},{"issue":"7","key":"4475_CR8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","volume":"84","author":"HS Smith","year":"2009","unstructured":"Smith HS. Opioid metabolism. Mayo Clin Proc. 2009;84(7):613\u201324.","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 11","key":"4475_CR9","first-page":"S276","volume":"17","author":"BR Overholser","year":"2011","unstructured":"Overholser BR, Foster DR. Opioid pharmacokinetic drug\u2013drug interactions. Am J Manag Care. 2011;17(Suppl 11):S276\u201387.","journal-title":"Am J Manag Care"},{"key":"4475_CR10","doi-asserted-by":"publisher","first-page":"e072415","DOI":"10.1136\/bmj-2022-072415","volume":"380","author":"GE Ferreira","year":"2023","unstructured":"Ferreira GE, Abdel-Shaheed C, Underwood M, Finnerup NB, Day RO, McLachlan A, et al. Efficacy, safety, and tolerability of antidepressants for pain in adults: overview of systematic reviews. BMJ. 2023;380:e072415.","journal-title":"BMJ"},{"key":"4475_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/DHPS.S151073","volume":"10","author":"KC Molina","year":"2018","unstructured":"Molina KC, Fairman KA, Sclar DA. Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits. Drug Healthc Patient Saf. 2018;10:37\u201343.","journal-title":"Drug Healthc Patient Saf"},{"issue":"1","key":"4475_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13195-021-00818-3","volume":"13","author":"YJ Wei","year":"2021","unstructured":"Wei YJ, Schmidt S, Chen C, Fillingim RB, Reid MC, DeKosky S, et al. Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia. Alzheimers Res Ther. 2021;13(1):78.","journal-title":"Alzheimers Res Ther"},{"key":"4475_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/JPR.S122853","volume":"10","author":"CS Zin","year":"2017","unstructured":"Zin CS, Ismail F. Co-prescription of opioids with benzodiazepines and other co-medications among opioid users: differential in opioid doses. J Pain Res. 2017;10:249\u201357.","journal-title":"J Pain Res"},{"issue":"2","key":"4475_CR14","doi-asserted-by":"publisher","first-page":"e220194","DOI":"10.1001\/jamanetworkopen.2022.0194","volume":"5","author":"I Yunusa","year":"2022","unstructured":"Yunusa I, Gagne JJ, Yoshida K, Bykov K. Risk of opioid overdose associated with concomitant use of oxycodone and selective serotonin reuptake inhibitors. JAMA Netw Open. 2022;5(2):e220194.","journal-title":"JAMA Netw Open"},{"issue":"14","key":"4475_CR15","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jama.2022.17735","volume":"328","author":"J Florian","year":"2022","unstructured":"Florian J, van der Schrier R, Gershuny V, Davis MC, Wang C, Han X, et al. Effect of paroxetine or quetiapine combined with oxycodone vs oxycodone alone on ventilation during hypercapnia: a randomized clinical trial. JAMA. 2022;328(14):1405\u201314.","journal-title":"JAMA"},{"unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or.","key":"4475_CR16"},{"unstructured":"U.S. Food and Drug Administration. FDA drug safety communication: FDA warns about several safety issues with opioid pain medicines; requires label changes. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-several-safety-issues-opioid-pain-medicines-requires.","key":"4475_CR17"},{"issue":"7","key":"4475_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jamainternmed.2020.0989","volume":"180","author":"K Bykov","year":"2020","unstructured":"Bykov K, He M, Gagne JJ. Trends in utilization of prescribed controlled substances in US commercially insured adults, 2004\u20132019. JAMA Intern Med. 2020;180(7):1006\u20138.","journal-title":"JAMA Intern Med"},{"issue":"8","key":"4475_CR19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758\u201364.","journal-title":"Am J Epidemiol"},{"issue":"24","key":"4475_CR20","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n MA, Wang W, Leaf DE. Target trial emulation: a framework for causal inference from observational data. JAMA. 2022;328(24):2446\u20137.","journal-title":"JAMA"},{"issue":"17","key":"4475_CR21","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1001\/archinternmed.2011.284","volume":"171","author":"M Nunez-Smith","year":"2011","unstructured":"Nunez-Smith M, Bradley EH, Herrin J, Santana C, Curry LA, Normand SL, et al. Quality of care in the US territories. Arch Intern Med. 2011;171(17):1528\u201340.","journal-title":"Arch Intern Med"},{"issue":"4","key":"4475_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/acem.13121","volume":"24","author":"C Rowe","year":"2017","unstructured":"Rowe C, Vittinghoff E, Santos GM, Behar E, Turner C, Coffin PO. Performance measures of diagnostic codes for detecting opioid overdose in the emergency department. Acad Emerg Med. 2017;24(4):475\u201383.","journal-title":"Acad Emerg Med"},{"issue":"2","key":"4475_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/0033354920904087","volume":"135","author":"S Slavova","year":"2020","unstructured":"Slavova S, Quesinberry D, Costich JF, et al. ICD-10-CM-based definitions for emergency department opioid poisoning surveillance: electronic health record case confirmation study. Public Health Rep. 2020;135(2):262\u20139.","journal-title":"Public Health Rep"},{"issue":"14","key":"4475_CR24","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMsm1605385","volume":"377","author":"MA Hern\u00e1n","year":"2017","unstructured":"Hern\u00e1n MA, Robins JM. Per-protocol analyses of pragmatic trials. N Engl J Med. 2017;377(14):1391\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"4475_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1740774511420743","volume":"9","author":"MA Hern\u00e1n","year":"2012","unstructured":"Hern\u00e1n MA, Hern\u00e1ndez-D\u00edaz S. Beyond the intention-to-treat in comparative effectiveness research. Clin Trials. 2012;9(1):48\u201355.","journal-title":"Clin Trials"},{"issue":"7","key":"4475_CR26","doi-asserted-by":"publisher","first-page":"515","DOI":"10.7326\/M17-3354","volume":"168","author":"MA Hern\u00e1n","year":"2018","unstructured":"Hern\u00e1n MA, Scharfstein D. Cautions as regulators move to end exclusive reliance on intention to treat. Ann Intern Med. 2018;168(7):515\u20136.","journal-title":"Ann Intern Med"},{"issue":"5","key":"4475_CR27","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/jama.2021.2825","volume":"326","author":"VA Smith","year":"2021","unstructured":"Smith VA, Coffman CJ, Hudgens MG. Interpreting the results of intention-to-treat, per-protocol, and as-treated analyses of clinical trials. JAMA. 2021;326(5):433\u20134.","journal-title":"JAMA"},{"issue":"12","key":"4475_CR28","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/MLR.0000000000000824","volume":"55","author":"JW Sun","year":"2017","unstructured":"Sun JW, Rogers JR, Her Q, Welch EC, Panozzo CA, Toh S, et al. Adaptation and validation of the combined comorbidity score for ICD-10-CM. Med Care. 2017;55(12):1046\u201351.","journal-title":"Med Care"},{"issue":"8","key":"4475_CR29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/gerona\/gly197","volume":"74","author":"DH Kim","year":"2019","unstructured":"Kim DH, Glynn RJ, Avorn J, Lipsitz LA, Rockwood K, Pawar A, et al. Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study. J Gerontol A Biol Sci Med Sci. 2019;74(8):1271\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"4475_CR30","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/gerona\/glx229","volume":"73","author":"DH Kim","year":"2018","unstructured":"Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J. Measuring frailty in Medicare data: development and validation of a claims-based frailty index. J Gerontol A Biol Sci Med Sci. 2018;73(7):980\u20137.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"4475_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399\u2013424.","journal-title":"Multivar Behav Res"},{"issue":"2","key":"4475_CR32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1515\/ijb-2012-0030","volume":"9","author":"L Li","year":"2013","unstructured":"Li L, Greene T. A weighting analogue to pair matching in propensity score analysis. Int J Biostat. 2013;9(2):215\u201334.","journal-title":"Int J Biostat"},{"issue":"3","key":"4475_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/biomet\/87.3.706","volume":"87","author":"GW Imbens","year":"2000","unstructured":"Imbens GW. The role of the propensity score in estimating dose\u2013response functions. Biometrika. 2000;87(3):706\u201310.","journal-title":"Biometrika"},{"issue":"3","key":"4475_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/EDE.0000000000000627","volume":"28","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Hern\u00e1ndez-D\u00edaz S, Solomon DH, Jackson JW, Gagne JJ, Glynn RJ, et al. Matching weights to simultaneously compare three treatment groups: comparison to three-way matching. Epidemiology. 2017;28(3):387\u201395.","journal-title":"Epidemiology"},{"key":"4475_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.toxrep.2020.01.008","volume":"7","author":"L Xu","year":"2020","unstructured":"Xu L, Chockalingam A, Stewart S, Shea K, Matta MK, Narayanasamy S, et al. Developing an animal model to detect drug\u2013drug interactions impacting drug-induced respiratory depression. Toxicol Rep. 2020;7:188\u201397.","journal-title":"Toxicol Rep"},{"issue":"6","key":"4475_CR36","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/cts.13080","volume":"14","author":"L Xu","year":"2021","unstructured":"Xu L, Krishna A, Stewart S, Shea K, Racz R, Weaver JL, et al. Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat. Clin Transl Sci. 2021;14(6):2208\u201319.","journal-title":"Clin Transl Sci"},{"issue":"3","key":"4475_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1046\/j.1365-2125.2003.02002.x","volume":"57","author":"MR Hutchinson","year":"2004","unstructured":"Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA. CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes. Br J Clin Pharmacol. 2004;57(3):287\u201397.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"4475_CR38","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1124\/jpet.123.001651","volume":"387","author":"S Coates","year":"2023","unstructured":"Coates S, Lazarus P. Hydrocodone, oxycodone, and morphine metabolism and drug\u2013drug interactions. J Pharmacol Exp Ther. 2023;387(2):150\u201369.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"4475_CR39","doi-asserted-by":"publisher","first-page":"e986","DOI":"10.1542\/peds.2009-1907","volume":"126","author":"P Madadi","year":"2010","unstructured":"Madadi P, Hildebrandt D, Gong IY, Schwarz UI, Ciszkowski C, Ross CJ, et al. Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions. Pediatrics. 2010;126(4):e986\u20139.","journal-title":"Pediatrics"},{"issue":"2","key":"4475_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cpt.147","volume":"98","author":"JK Hicks","year":"2015","unstructured":"Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015;98(2):127\u201334.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"4475_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/YIC.0000000000000023","volume":"29","author":"C Sanchez","year":"2014","unstructured":"Sanchez C, Reines EH, Montgomery SA. A comparative review of escitalopram, paroxetine, and sertraline: are they all alike? Int Clin Psychopharmacol. 2014;29(4):185\u201396.","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"4475_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1177\/009127000004000108","volume":"40","author":"CL Alfaro","year":"2000","unstructured":"Alfaro CL, Lam YW, Simpson J, Ereshefsky L. CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations. J Clin Pharmacol. 2000;40(1):58\u201366.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"4475_CR43","doi-asserted-by":"publisher","first-page":"e0227966","DOI":"10.1371\/journal.pone.0227966","volume":"15","author":"SF Altekruse","year":"2020","unstructured":"Altekruse SF, Cosgrove CM, Altekruse WC, Jenkins RA, Blanco C. Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the mortality disparities in American Communities Study (MDAC). PLoS ONE. 2020;15(1):e0227966.","journal-title":"PLoS ONE"},{"issue":"4","key":"4475_CR44","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/dom.13184","volume":"20","author":"E Patorno","year":"2018","unstructured":"Patorno E, Gopalakrishnan C, Franklin JM, Brodovicz KG, Masso-Gonzalez E, Bartels DB, et al. Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records. Diabetes Obes Metab. 2018;20(4):974\u201384.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"4475_CR45","doi-asserted-by":"publisher","first-page":"e70088","DOI":"10.1002\/pds.70088","volume":"34","author":"C Chen","year":"2025","unstructured":"Chen C, Pham Nguyen TP, Hughes JE, Hennessy S, Leonard CE, Miano TA, et al. Evaluation of drug\u2013drug interactions in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2025;34(1):e70088.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-04475-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-04475-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T14:42:42Z","timestamp":1764340962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-04475-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4475"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-04475-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"type":"electronic","value":"1741-7015"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained at from the Brigham and Women\u2019s Hospital Institutional Review Board (IRB No. 2020P002865).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This study used de-identified secondary data sources and did not involve any individual participant data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KFH reports being an investigator on grants to Brigham and Women\u2019s Hospital from Takeda and UCB for unrelated work. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"666"}}